The Ambiguous Role of NKX2-5 Mutations in Thyroid Dysgenesis

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  van Engelen, Klaartje ^a,b   Mommersteeg, Mathilda T M ^a,c   Baars, Marieke J H ^a   Lam, Jan ^a   Ilgun, Aho ^a   van Trotsenburg, A S Paul ^a   Smets, Anne M J B ^a   Christoffels, Vincent M ^a   Mulder, Barbara J M ^a,b   Postma, Alex V ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR NKX2.5;

ADOLESCENT; ADULT; AGED; ANIMAL CELL; ARTICLE; CHILD; CONGENITAL HEART DISEASE; CONTROLLED STUDY; FEMALE; GENE FUNCTION; GENE SEQUENCE; GENETIC VARIABILITY; HEART DEVELOPMENT; HELA CELL; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MULTIGENE FAMILY; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROMOTER REGION; RAT; SCHOOL CHILD; THYROID DYSGENESIS; THYROID GLAND; TRANSACTIVATION; WILD TYPE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; ANIMALS; CELL NUCLEUS; CHILD; DNA-BINDING PROTEINS; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; MALE; MIDDLE AGED; MUTATION; PEDIGREE; PHENOTYPE; PROMOTER REGIONS, GENETIC; PROTEIN TRANSPORT; SEQUENCE ALIGNMENT; THYROID DYSGENESIS; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; YOUNG ADULT;

RATTUS;

EID: 84871685456     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052685     Document Type: Article

References (37)

1. Kempers MJ, Lanting CI, van Heijst AF, van Trotsenburg AS, Wiedijk BM, et al. (2006) Neonatal screening for congenital hypothyroidism based on thyroxine, thyrotropin, and thyroxine-binding globulin measurement: potentials and pitfalls. J Clin Endocrinol Metab 91: 3370-3376.
2. van Vliet G, (2003) Development of the thyroid gland: lessons from congenitally hypothyroid mice and men. Clin Genet 63: 445-455.
3. Castanet M, Polak M, Bonaiti-Pellie C, Lyonnet S, Czernichow P, et al. (2001) Nineteen years of national screening for congenital hypothyroidism: familial cases with thyroid dysgenesis suggest the involvement of genetic factors. J Clin Endocrinol Metab 86: 2009-2014.
4. Krude H, Schutz B, Biebermann H, von MA, Schnabel D, et al. (2002) Choreoathetosis, hypothyroidism, and pulmonary alterations due to human NKX2-1 haploinsufficiency. J Clin Invest 109: 475-480.
5. Clifton-Bligh RJ, Wentworth JM, Heinz P, Crisp MS, John R, et al. (1998) Mutation of the gene encoding human TTF-2 associated with thyroid agenesis, cleft palate and choanal atresia. Nat Genet 19: 399-401.
6. Macchia PE, Lapi P, Krude H, Pirro MT, Missero C, et al. (1998) PAX8 mutations associated with congenital hypothyroidism caused by thyroid dysgenesis. Nat Genet 19: 83-86.
7. Sunthornthepvarakui T, Gottschalk ME, Hayashi Y, Refetoff S, (1995) Brief report: resistance to thyrotropin caused by mutations in the thyrotropin-receptor gene. N Engl J Med 332: 155-160.
8. Dentice M, Cordeddu V, Rosica A, Ferrara AM, Santarpia L, et al. (2006) Missense mutation in the transcription factor NKX2-5: a novel molecular event in the pathogenesis of thyroid dysgenesis. J Clin Endocrinol Metab 91: 1428-1433.
9. Fagman H, Nilsson M, (2011) Morphogenetics of early thyroid development. J Mol Endocrinol 46: R33-R42.
10. Bartlett H, Veenstra GJ, Weeks DL, (2010) Examining the cardiac NK-2 genes in early heart development. Pediatr Cardiol 31: 335-341.
11. Schott JJ, Benson DW, Basson CT, Pease W, Silberbach GM, et al. (1998) Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 281: 108-111.
12. Reamon-Buettner SM, Borlak J, (2010) NKX2-5: an update on this hypermutable homeodomain protein and its role in human congenital heart disease (CHD). Hum Mutat 31: 1185-1194.
13. Olivieri A, Stazi MA, Mastroiacovo P, Fazzini C, Medda E, et al. (2002) A population-based study on the frequency of additional congenital malformations in infants with congenital hypothyroidism: data from the Italian Registry for Congenital Hypothyroidism (1991-1998). J Clin Endocrinol Metab 87: 557-562.
14. Passeri E, Frigerio M, De FT, Valaperta R, Capelli P, et al. (2011) Increased Risk for Non-Autoimmune Hypothyroidism in Young Patients with Congenital Heart Defects. J Clin Endocrinol Metab: E1115-E1119.
15. Ramos HE, Nesi-Franca S, Boldarine VT, Pereira RM, Chiamolera MI, et al. (2009) Clinical and molecular analysis of thyroid hypoplasia: a population-based approach in southern Brazil. Thyroid 19: 61-68.
16. van der Velde ET, Vriend JW, Mannens MM, Uiterwaal CS, Brand R, et al. (2005) CONCOR, an initiative towards a national registry and DNA-bank of patients with congenital heart disease in the Netherlands: rationale, design, and first results. Eur J Epidemiol 20: 549-557.
17. Lennon G, Auffray C, Polymeropoulos M, Soares MB, (1996) The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expression. Genomics 33: 151-152.
18. Postma AV, van de Meerakker JB, Mathijssen IB, Barnett P, Christoffels VM, et al. (2008) A gain-of-function TBX5 mutation is associated with atypical Holt-Oram syndrome and paroxysmal atrial fibrillation. Circ Res 102: 1433-1442.
19. Jahn L, Sadoshima J, Greene A, Parker C, Morgan KG, et al. (1996) Conditional differentiation of heart- and smooth muscle-derived cells transformed by a temperature-sensitive mutant of SV40 T antigen. J Cell Sci 109 (Pt 2): 397-407.
20. Gey GO, Coffman WD, Kubicek MT, (1952) Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Res 12: 264-265.
21. Ruijter JM, Thygesen HH, Schoneveld OJ, Das AT, Berkhout B, et al. (2006) Factor correction as a tool to eliminate between-session variation in replicate experiments: application to molecular biology and retrovirology. Retrovirology 3: 2.
22. Gluzman Y, (1981) SV40-transformed simian cells support the replication of early SV40 mutants. Cell 23: 175-182.
23. Tennessen JA, Bigham AW, O'Connor TD, Fu W, Kenny EE, et al. (2012) Evolution and Functional Impact of Rare Coding Variation from Deep Sequencing of Human Exomes. Science 337: 64-69.
24. Dean DS, Gharib H, (2008) Epidemiology of thyroid nodules. Best Pract Res Clin Endocrinol Metab 22: 901-911.
25. Spencer CA, Hollowell JG, Kazarosyan M, Braverman LE, (2007) National Health and Nutrition Examination Survey III thyroid-stimulating hormone (TSH)-thyroperoxidase antibody relationships demonstrate that TSH upper reference limits may be skewed by occult thyroid dysfunction. J Clin Endocrinol Metab 92: 4236-4240.
26. Habets PE, Moorman AF, Clout DE, van Roon MA, Lingbeek M, et al. (2002) Cooperative action of Tbx2 and Nkx2.5 inhibits ANF expression in the atrioventricular canal: implications for cardiac chamber formation. Genes Dev 16: 1234-1246.
27. Benson DW, Silberbach GM, Kavanaugh-McHugh A, Cottrill C, Zhang Y, et al. (1999) Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways. J Clin Invest 104: 1567-1573.
28. Kasahara H, Lee B, Schott JJ, Benson DW, Seidman JG, et al. (2000) Loss of function and inhibitory effects of human CSX/NKX2.5 homeoprotein mutations associated with congenital heart disease. J Clin Invest 106: 299-308.
29. Lints TJ, Parsons LM, Hartley L, Lyons I, Harvey RP, (1993) Nkx-2.5: a novel murine homeobox gene expressed in early heart progenitor cells and their myogenic descendants. Development 119: 419-431.
30. Hermanns P, Grasberger H, Refetoff S, Pohlenz J, (2011) Mutations in the NKX2.5 Gene and the PAX8 Promoter in a Girl with Thyroid Dysgenesis. J Clin Endocrinol Metab 96: E977-E981.
31. Beffagna G, Cecchetto A, Dal BL, Lorenzon A, Angelini A, et al. (2012) R25C mutation in the NKX2.5 gene in Italian patients affected with non-syndromic and syndromic congenital heart disease. J Cardiovasc Med (Hagerstown).
32. Cangul H, Morgan NV, Forman JR, Saglam H, Aycan Z, et al. (2010) Novel TSHR mutations in consanguineous families with congenital nongoitrous hypothyroidism. Clin Endocrinol (Oxf) 73: 671-677.
33. Al Taji E, Biebermann H, Limanova Z, Hnikova O, Zikmund J, et al. (2007) Screening for mutations in transcription factors in a Czech cohort of 170 patients with congenital and early-onset hypothyroidism: identification of a novel PAX8 mutation in dominantly inherited early-onset non-autoimmune hypothyroidism. Eur J Endocrinol 156: 521-529.
34. Brust ES, Beltrao CB, Chammas MC, Watanabe T, Sapienza MT, et al. (2012) Absence of mutations in PAX8, NKX2.5, and TSH receptor genes in patients with thyroid dysgenesis. Arq Bras Endocrinol Metabol 56: 173-177.
35. Narumi S, Muroya K, Asakura Y, Adachi M, Hasegawa T, (2010) Transcription factor mutations and congenital hypothyroidism: systematic genetic screening of a population-based cohort of Japanese patients. J Clin Endocrinol Metab 95: 1981-1985.
36. Lyons I, Parsons LM, Hartley L, Li R, Andrews JE, et al. (1995) Myogenic and morphogenetic defects in the heart tubes of murine embryos lacking the homeo box gene Nkx2-5. Genes Dev 9: 1654-1666.
37. Biben C, Weber R, Kesteven S, Stanley E, McDonald L, et al. (2000) Cardiac septal and valvular dysmorphogenesis in mice heterozygous for mutations in the homeobox gene Nkx2-5. Circ Res 87: 888-895.